
Amanda Marie Haney
Examiner (ID: 4279, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1000 |
| Issued Applications | 285 |
| Pending Applications | 140 |
| Abandoned Applications | 613 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20414388
[patent_doc_number] => 12497661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Method of improving prediction of response for cancer patients treated with immunotherapy
[patent_app_type] => utility
[patent_app_number] => 16/685439
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 8962
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685439 | Method of improving prediction of response for cancer patients treated with immunotherapy | Nov 14, 2019 | Issued |
Array
(
[id] => 17627678
[patent_doc_number] => 20220162693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MASSIVELY PARALLEL SEQUENCING USING UNLABELED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/291962
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291962 | MASSIVELY PARALLEL SEQUENCING USING UNLABELED NUCLEOTIDES | Nov 10, 2019 | Pending |
Array
(
[id] => 15899181
[patent_doc_number] => 20200149109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Method to Predict Response to Neuropsychiatric Drugs Using Variation in the Serotonin 7 Receptor (HTR7) Gene
[patent_app_type] => utility
[patent_app_number] => 16/678855
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678855 | Method to predict response to neuropsychiatric drugs using variation in the serotonin 7 receptor (HTR7) gene | Nov 7, 2019 | Issued |
Array
(
[id] => 17801283
[patent_doc_number] => 11415577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Method of detecting bio-material
[patent_app_type] => utility
[patent_app_number] => 16/669181
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 3981
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/669181 | Method of detecting bio-material | Oct 29, 2019 | Issued |
Array
(
[id] => 16177310
[patent_doc_number] => 20200224278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING EPITHELIAL CELL DNA
[patent_app_type] => utility
[patent_app_number] => 16/665731
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665731
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/665731 | Compositions comprising ZDHHC1 DNA in a complex | Oct 27, 2019 | Issued |
Array
(
[id] => 16223152
[patent_doc_number] => 20200248268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Method For Estimating A Risk For A Subject Suffering From Urothelial Carcinoma And Kit Thereof
[patent_app_type] => utility
[patent_app_number] => 16/658754
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/658754 | Method For Estimating A Risk For A Subject Suffering From Urothelial Carcinoma And Kit Thereof | Oct 20, 2019 | Abandoned |
Array
(
[id] => 17913611
[patent_doc_number] => 20220316006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PLASMA AND CEREBROSPINAL FLUID MIRNA BIOMARKERS IN INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE
[patent_app_type] => utility
[patent_app_number] => 17/286411
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286411 | PLASMA AND CEREBROSPINAL FLUID MIRNA BIOMARKERS IN INTRACEREBRAL AND SUBARACHNOID HEMORRHAGE | Oct 15, 2019 | Abandoned |
Array
(
[id] => 17830530
[patent_doc_number] => 20220267834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT (+)-CATECHIN CONTENT
[patent_app_type] => utility
[patent_app_number] => 17/254302
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254302 | MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT (+)-CATECHIN CONTENT | Oct 13, 2019 | Abandoned |
Array
(
[id] => 17548544
[patent_doc_number] => 20220119885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY
[patent_app_type] => utility
[patent_app_number] => 17/282318
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282318 | DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY | Oct 8, 2019 | Pending |
Array
(
[id] => 15963865
[patent_doc_number] => 20200165684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/585876
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585876 | COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER | Sep 26, 2019 | Abandoned |
Array
(
[id] => 19152168
[patent_doc_number] => 11977076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
[patent_app_type] => utility
[patent_app_number] => 16/579798
[patent_app_country] => US
[patent_app_date] => 2019-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27111
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/579798 | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells | Sep 22, 2019 | Issued |
Array
(
[id] => 15364283
[patent_doc_number] => 20200017906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => USE OF PIRNA-54265 IN DIAGNOSIS, TREATMENT, AND PROGNOSTIC EVALUATION OF COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 16/576746
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/576746 | USE OF PIRNA-54265 IN DIAGNOSIS, TREATMENT, AND PROGNOSTIC EVALUATION OF COLORECTAL CANCER | Sep 18, 2019 | Abandoned |
Array
(
[id] => 17483600
[patent_doc_number] => 20220091104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ANALYSIS OF POLYMORPHISMS IN SIRP-ALPHA FOR EVALUATING RESPONSE TO IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/276052
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276052 | ANALYSIS OF POLYMORPHISMS IN SIRP-ALPHA FOR EVALUATING RESPONSE TO IMMUNOTHERAPY | Sep 10, 2019 | Abandoned |
Array
(
[id] => 17505581
[patent_doc_number] => 20220098683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTION OF HPV DNA AND DIAGNOSIS AND MONITORING OF HPV-ASSOCIATED CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/196631
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196631
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196631 | METHODS AND COMPOSITIONS FOR DETECTION OF HPV DNA AND DIAGNOSIS AND MONITORING OF HPV-ASSOCIATED CANCERS | Sep 9, 2019 | Pending |
Array
(
[id] => 17126572
[patent_doc_number] => 20210301341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS FOR MEASURING RIBOSOMAL METHYLATION AGE
[patent_app_type] => utility
[patent_app_number] => 17/266492
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266492 | METHODS FOR MEASURING RIBOSOMAL METHYLATION AGE | Aug 15, 2019 | Abandoned |
Array
(
[id] => 15414481
[patent_doc_number] => 20200027563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => Method of Assessing Risk
[patent_app_type] => utility
[patent_app_number] => 16/530353
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530353 | Method of Assessing Risk | Aug 1, 2019 | Abandoned |
Array
(
[id] => 17126571
[patent_doc_number] => 20210301340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHOD OF EVALUATING QUALITY OF BODY FLUID SPECIMEN
[patent_app_type] => utility
[patent_app_number] => 17/264689
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264689 | METHOD OF EVALUATING QUALITY OF BODY FLUID SPECIMEN | Jul 29, 2019 | Pending |
Array
(
[id] => 17112243
[patent_doc_number] => 20210292840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => SMALL RNA PREDICTORS FOR ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/262045
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262045 | SMALL RNA PREDICTORS FOR ALZHEIMER'S DISEASE | Jul 24, 2019 | Abandoned |
Array
(
[id] => 18478495
[patent_doc_number] => 11692227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Method for screening for skin whitening agent by using SDF1 promoter region
[patent_app_type] => utility
[patent_app_number] => 17/262749
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2817
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262749 | Method for screening for skin whitening agent by using SDF1 promoter region | Jul 16, 2019 | Issued |
Array
(
[id] => 15039387
[patent_doc_number] => 20190330698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => DIABETES POLYGENIC RISK SCORE
[patent_app_type] => utility
[patent_app_number] => 16/510817
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510817 | DIABETES POLYGENIC RISK SCORE | Jul 11, 2019 | Abandoned |